Logo image
Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion
Journal article   Open access   Peer reviewed

Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion

Weihong Zhou, Yulong Zhang, Micaela S HOSCH, Amie LANG, Ralf M ZWACKA and John F ENGELHARDT
Hepatology (Baltimore, Md.), Vol.33(4), pp.902-914
2001
DOI: 10.1053/jhep.2001.23073
PMID: 11283855
url
https://doi.org/10.1053/jhep.2001.23073View
Published (Version of record) Open Access

Abstract

Acute damage following ischemia and reperfusion (I/R) in the liver is in part caused by the generation of reactive oxygen species, such as superoxides, during the reperfusion event. Gene therapy directed at attenuating mitochondrial superoxide production following warm I/R injury in the liver has demonstrated great promise in reducing acute hepatocellular damage. In the present study, we have compared the therapeutic effects of ectopic expression of mitochondrial (MnSOD) and cytoplasmic (Cu/ZnSOD) superoxide dismutase using recombinant adenoviral vectors for reducing I/R damage in the liver. Consistent with previous observations, recombinant adenoviral delivery of MnSOD to the liver significantly attenuated both acute liver damage and AP‐1 activation following I/R injury to the livers of mice. However, ectopic expression of Cu/ZnSOD diminished neither I/R‐induced elevations in serum alanine transaminase (ALT) nor AP‐1 activation. Interestingly, baseline activation of AP‐1 before I/R‐induced injury was seen in livers infected with recombinant Ad.Cu/ZnSOD, but not Ad.MnSOD or Ad.LacZ, vectors. The level of Cu/ZnSOD‐induced AP‐1 activation was significantly reduced by ablation of Kupffer cells or by coexpression of catalase, suggesting that increased H2O2 production facilitated by Cu/ZnSOD in hepatocytes and/or Kupffer cells may be responsible for AP‐1 activation. In vitro reconstitution studies using hepatocyte and macrophage cell lines demonstrated that Cu/ZnSOD overexpression induces AP‐1 in both cell types, and that secretion of a Cu/ZnSOD‐induced macrophage factor is capable of elevating AP‐1 in hepatocytes. In summary, our findings demonstrate that subcellular sites of superoxide production in the liver can differentially affect the outcome of I/R injury in the liver and selectively influence AP‐1 activation.
Gastroenterology. Liver. Pancreas. Abdomen Biological and medical sciences Medical sciences Liver. Biliary tract. Portal circulation. Exocrine pancreas Other diseases. Semiology

Details

Metrics

Logo image